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Letters to the Editor Erythrocyte Aggregation in Nonvalvular Atrial Fibrillation
To the Editor:
To date, data on the hemorheological makeup in nonvalvular atrial fibrillation (AF) (1) (2) (3) (4) (5) are scarce. Recently, more attention has been paid to the presence or absence in this condition of left atrial spontaneous echocontrast (SEC) defined as a cloud of echoes swirling in the left atrial cavity. The SEC, a marker of low atria! blood velocity and increased atrial size and considered a predictor of thromboembolic events (2,6,7), seems in particular to depend on erythrocyte aggregation (EA) (2, 3, 8) . As is known, EA is the most important factor in the non-Newtonian behavior of normal human blood; this is a reversible dynamic process, and data suggest that this parameter is related to elevated plasma fibrinogen and globulin levels that are aggregation determinants.
Recently we evaluated the EA in subjects with nonvalvular AF and examined this hemorheological parameter according to the presence or absence of this echocardiographic sign. In this open study, all subjects (20 men and 15 women; mean age, 64.7 ± 13.7 years) with nanvalvular AF, ascertained by transthoracic echocardiographic study, were examined, after informed consent, with tran~e~c~ph~.~~al echocardiography, and in this study, the left atrium was inspected for the presence or ' absence of SEC.
Before transesophageal echocardiography was per-I formed, we examined the EA using the aggregometer MA. 1 .05; AF with SEC, 19.37 ± 5.26; p < 0.01), although no statistical difference in this determinant was found between the two AF groups.
In subjects with and without SEC, no statistical correlation was observed between EA and the echocardiographic parameters distinguishing the two AF groups, such as LAAmin (expressed as CM2 and reflecting the minimum area of left atrial appendage) and V max positive (expressed as cm/s and reflecting the left atrial appendage flow obtained evaluating the peak filling velocity). This study found that the EA discriminates controls from nc~nva.lvular AF subjects, and this finding was expected because in most AF subjects, the underlying heart disease (coronary artery disease, hypertensive heart disease, chronic heart failure, dilatative cardiomyopathy) was characterized by a hyperviscous condition. However, the EA does not distinguish AF subjects with and without SEC nor were the values of this macrorheologial parameter rel~:ted to the echocardiographic parameters.
Considering the small number of nonvalvular AF subjects with SEC, we did not distinguish the grades of such an echocardiographic phenomenon. We will find it useful to investigate it further because nc~nvalvul~r AF is associated with a major thromboembolic risk. 
